- Forums
- ASX - By Stock
- NTI
- Ann: Phase I/II PANDAS/PANS Clinical Trial Meets Primary Endpoint
Ann: Phase I/II PANDAS/PANS Clinical Trial Meets Primary Endpoint, page-20
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.9¢ |
Change
0.002(3.51%) |
Mkt cap ! $61.04M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.8¢ | $40.37K | 687.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 116886 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 167176 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 116886 | 0.058 |
2 | 140265 | 0.057 |
3 | 127571 | 0.056 |
3 | 1169000 | 0.055 |
2 | 571649 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 167176 | 3 |
0.060 | 317015 | 7 |
0.061 | 481997 | 3 |
0.064 | 200000 | 1 |
0.065 | 56436 | 2 |
Last trade - 13.05pm 15/11/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online